http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Celebrity Homes: Taylor Swift Purchased and Restored the Samuel Goldwyn Estate in Beverly Hills
-
Hungry Howie's Ignites Summer with Limited-Time TNT Flavored Crust®, Available Starting June 23
-
Bojangles Rolls Out New Breakfast Bo-Rito — A Bold, Portable Take on Classic Morning Favorites
-
Anti-Poverty Nonprofit Oyate Group Celebrates Its Five-Year Anniversary
-
Digits Launches First AI Agents for Accounting Workflows, Built on Digits Autonomous General Ledger
-
BitMart Launches X Insight: A Breakthrough AI Tool That Translates Crypto Conversations Into Market Intelligence
-
HII Celebrates First Meal Aboard Virginia-Class Submarine Massachusetts (SSN 798)
-
Karmanos Cancer Institute Celebrates Survivorship and Strength During National Cancer Survivors Month
-
Brookmount Gold Announces Completion of Audit and Issue of Audit Opinion for Financial years 2021/22
-
Sharecare wins 21 Digital Health Awards in Spring 2025 competition
-
Matt Maddox Joins DirectDefense as Vice President of Professional Services
-
ESGold Corp. Secures $3.3 Million Financing to Advance into Near-Term Gold Production
-
Capstone Green Energy (CGEH) names Christopher Close to Board
-
Capstone Green Energy Appoints Christopher Close to Its Board of Directors
-
Bedrock's BR/USDT Pool Trading Volume Surpasses $13.2 Billion with Over 341,000 Traders in 5 Days
-
Mitsubishi Tanabe Pharma America Marks Three Years Since Launch of RADICAVA ORS® (edaravone) in the U.S.
-
Genprex Collaborators Present Research on Non-Viral Approach to Diabetes Gene Therapy Using Lipid Nanoparticle Delivery System at the 2025 American Diabetes Association 85th Scientific Sessions
-
Affinity Interactive’s Daily Racing Form Partners with Horseshoe Indianapolis to Launch Groundbreaking AI Handicapping Technology for 2025 Racing Season
-
PracticeLink Announces Strategic Leadership Realignment to Advance Service to Physicians and Recruiters
-
Anchorage Digital Adopts Uniswap’s API Enabling Institutional Access to DeFi Liquidity
-
General Enterprise Ventures Strengthens Canada's Wildfire Defense in Partnership with Global Fire Rescue
-
Conduent to Showcase Innovative 3D Fare Gates and Other Transit Technologies at Transport Ticketing North America
-
Worksport Reports Consecutive Months of Record-Breaking Revenues, Gross Margin Improves by 25%
-
ReElement Technologies Corporation and Pensana PLC Join Forces to Advance One of Largest Global Rare Earth Oxide Supply Chain Partnerships
-
Arcturus Therapeutics to Host Key Opinion Leader (KOL) Presentation of ARCT-810 Phase 2 Interim Data for Ornithine Transcarbamylase (OTC) Deficiency
-
ValueSelling Associates Launches AI Avatar Sales Coach, “Val”
-
Telvantis Inc. Closes May 25 With $20.6M+ in Revenue; Confirms Full Year Plan in Excess of $200M in Revenues and Strong Commercial Momentum
-
John Wiley & Sons, Inc. (WLY) Appoints Craig Albright as CFO
-
Coalfire Sets the Bar for Responsible AI, Unveiling Industry's First ISO 42001 Certification and Comprehensive Model Testing Program
-
Anixa Biosciences (ANIX) Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial
-
Toshiba Automates Busywork, Frees Time
-
Johnson & Johnson Launches First and Only Daily Disposable Multifocal Toric Contact Lens - ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM
-
Wiley Appoints Craig Albright as Executive Vice President and Chief Financial Officer
-
Scholar Rock to Present Comprehensive Update at 2025 Annual Cure SMA Research and Clinical Care Meeting, Including Positive Results from Pivotal Phase 3 SAPPHIRE Trial
-
FIFA, NBA, UFC and More Sports Events Go Live – Crypto Sportsbook BETY Offers Global Sports Betting Coverage 2025
-
Guardforce AI Strengthens Decade-Long Client Relationships by Securing Long-term Contract with Government Savings Bank
-
Anixa Biosciences Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial
-
Telvantis Inc. Closes May 25 With $20.6M+ in Revenue; Confirms Full Year Plan in Excess of $200M in Revenues and Strong Commercial Momentum
-
Quanterix (QTRX) Expands Reach with IVD and Large Reference Labs
-
Arrowhead Pharmaceuticals Completes Enrollment in SHASTA-3, SHASTA-4, and MUIR-3 Phase 3 Studies of Plozasiran
-
Quanterix Expands Reach with IVD and Large Reference Labs
-
Turnium Technology Group and Syntheia AI Forge Global Strategic Alliance to Accelerate AI Innovation and Market Reach
-
Palvella Therapeutics Completes Enrollment in Phase 3 SELVA Trial of QTORIN™ Rapamycin for Microcystic Lymphatic Malformations, Exceeding Enrollment Target by Over 25%
-
OpRegen® (RG6501) 36-Month Visual Acuity Results Featured at Clinical Trials at the Summit 2025
-
SIROCCO BY LEBUA AWARDED TWO FORKS BY GAMBERO ROSSO
-
Aclaris Therapeutics Initiates Phase 1a/1b Program for its Novel Bispecific Antibody ATI-052
-
Merck (MRK) Announces Phase 3 HYPERION Study of WINREVAIR Met Primary Endpoint
-
Merck Announces Phase 3 HYPERION Study of WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint in Recently Diagnosed Adults with Pulmonary Arterial Hypertension (PAH)
-
BYDFi MoonX Launches Global KOL Recruitment to Accelerate the On-Chain Trading Ecosystems
-
Vanilla Finance Rebrands to Superp, A Meme-Fueled Perp DEX
